Research identifies cause of IBS pain as ‘gut itch’
New research has identified the cause of IBS pain as 'gut itch'. 11 percent of the world’s population experience Irritable Bowel Syndrome (IBS), but the...
The annual assessment of health and social care in England
The Care Quality Commission (CQC) has published its annual assessment of health and social care in England. It looks at the trends, highlights examples...
Chief Medical Officer’s report calls for childhood obesity to be prioritised
An independent report by former Chief Medical Officer (CMO) Professor Dame Sally Davies calls for childhood obesity to be prioritised. In her report ‘Time to...
Understanding community pharmacy contractual framework
Deborah Evans FFRPS FRPharmS FRSPH, Managing Director of Pharmacy Complete, investigates what the new community pharmacy contractual framework (CPCF) means for pharmacy. The CPCF was...
New restrictions on exporting HRT to tackle drug shortages
There will be new restrictions on exporting HRT products, which currently face supply shortages due to manufacturing issues. The Government has confirmed new restrictions on...
Impact of Brexit on health and social care supply: NAO report
The National Audit Office (NAO) has published a report exploring the impact of Brexit on health and social care supply. It says that there is...
‘Room for improvement’ in support for women with cancer
Merck has released the Supporting Women With Cancer report, presenting findings from a global survey of 4585 women across 23 countries. The survey revealed that...
Research into effectiveness of AI at diagnosing disease
The first systematic review and meta-analysis into the effectiveness of AI at diagnosing disease suggests artificial intelligence may be as effective as health professionals. But...
Poor diabetes control costs the NHS £3bn in avoidable treatment
New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Early signs of adult type 2 diabetes visible in 8 year olds
Early signs of adult type 2 diabetes can be seen in children as young as 8 years old, decades before it is likely to...
Latest articles
Mind the Generation Gap in pharma marketing and market research
Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
AstraZeneca presents anifrolumab results from Phase III TULIP trial
Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Popular articles
NHS Commercial Framework for Medicines consultation published
NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Mapping NHS change is key to customer engagement
Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Pf Power List 2019: Who is shaping the pharma & healthcare sector?
The Pf Power List has looked at who is making a difference in pharma and healthcare in 2019. This year has brought a range of developments...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Medopad and Janssen collaborate on novel digital biomarker for Alzheimer’s disease
Medopad has announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and...